Paysign, Inc. (NASDAQ:PAYS - Get Free Report) EVP Joan Herman sold 30,000 shares of the firm's stock in a transaction that occurred on Monday, November 16th. The shares were sold at an average price of $9.30, for a total value of $279,000.00. Following the completion of the sale, the executive vice president directly owned 579,421 shares of the company's stock, valued at approximately $5,388,615.30. The trade was a 4.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Paysign Stock Up 2.8%
Shares of NASDAQ PAYS traded up $0.27 during midday trading on Tuesday, hitting $9.81. 1,643,783 shares of the company's stock were exchanged, compared to its average volume of 1,283,349. Paysign, Inc. has a 12 month low of $3.08 and a 12 month high of $16.15. The company's 50 day moving average price is $13.50 and its 200 day moving average price is $8.76. The firm has a market capitalization of $557.70 million, a PE ratio of 28.91 and a beta of 0.92.
Paysign (NASDAQ:PAYS - Get Free Report) last posted its earnings results on Monday, November 9th. The company reported $0.11 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.02. Paysign had a return on equity of 35.29% and a net margin of 18.48%. The business had revenue of $30.80 million for the quarter, compared to analyst estimates of $29.02 million. On average, equities research analysts anticipate that Paysign, Inc. will post 0.62 EPS for the current year.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in PAYS. Allworth Financial LP increased its position in Paysign by 456.1% during the 3rd quarter. Allworth Financial LP now owns 3,042 shares of the company's stock worth $41,000 after buying an additional 2,495 shares during the period. Cetera Investment Advisers boosted its position in shares of Paysign by 21.4% in the third quarter. Cetera Investment Advisers now owns 17,879 shares of the company's stock valued at $241,000 after acquiring an additional 3,146 shares during the period. Legal & General Group Plc bought a new stake in shares of Paysign in the second quarter valued at about $35,000. D.A. Davidson & CO. grew its stake in shares of Paysign by 38.4% in the third quarter. D.A. Davidson & CO. now owns 18,323 shares of the company's stock valued at $247,000 after acquiring an additional 5,082 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC grew its stake in shares of Paysign by 11.4% in the first quarter. Allspring Global Investments Holdings LLC now owns 65,853 shares of the company's stock valued at $389,000 after acquiring an additional 6,717 shares in the last quarter. 25.89% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on the stock. Ladenburg Thalmann & Co. Inc. increased their price objective on shares of Paysign from $14.00 to $15.25 and gave the company a "buy" rating in a research report on Wednesday, November 11th. Lake Street Capital lifted their target price on shares of Paysign from $13.00 to $15.00 and gave the stock a "buy" rating in a report on Tuesday, September 15th. DA Davidson decreased their price target on shares of Paysign from $15.00 to $14.00 and set a "buy" rating on the stock in a research note on Wednesday, November 11th. Maxim Group cut shares of Paysign from a "buy" rating to a "hold" rating in a report on Wednesday, November 11th. Finally, Barrington Research set a $15.00 price target on shares of Paysign in a report on Tuesday, August 11th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $14.81.
Get Our Latest Report on Paysign
Paysign Company Profile
(
Get Free Report)
Paysign, Inc. provides prepaid card programs, payment processing and related financial technology services. Its platform supports organizations that need to distribute funds and manage payments, including businesses in the healthcare sector. The company serves plasma collection centers with donor compensation and payment solutions, and works with pharmaceutical companies on patient assistance and affordability programs. Its services also support payments for clinical trials and other disbursement needs.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Paysign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Paysign wasn't on the list.
While Paysign currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.